Literature DB >> 17371988

Enhanced NFATc1 nuclear occupancy causes T cell activation independent of CD28 costimulation.

Minggui Pan1, Monte M Winslow, Lei Chen, Ann Kuo, Dean Felsher, Gerald R Crabtree.   

Abstract

TCR signals induce the nuclear localization of NFATc proteins, which are removed from the nucleus after rephosphorylation by glycogen synthase kinase 3 and other kinases. Rapid nuclear export might allow continuous monitoring of receptor occupancy, making the transcriptional response proportional to the duration of TCR/CD28 signaling. To investigate this possibility, we analyzed mice in which T cells express a NFATc1 variant (NFATc1(nuc)) with serine-to-alanine changes at the glycogen synthase kinase 3 phosphorylation sites. NFATc1(nuc) T cells have constitutively nuclear NFATc1, enhanced T cell activation in vivo, and calcineurin-independent proliferation in vitro. NFATc1(nuc) T cells are hypersensitive to TCR/CD3 stimulation, resulting in enhanced proliferation and cytokine production that is independent of CD28 costimulation. These results support the notion that CD28 inhibits nuclear export of NFATc transcription factors. In addition, NFATc1(nuc) destabilizes a positive feedback loop in which NFATc1 activates its own transcription as well as its targets, such as CD40 ligand and Th1/Th2 cytokines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17371988     DOI: 10.4049/jimmunol.178.7.4315

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  An enigmatic tail of CD28 signaling.

Authors:  Jonathan S Boomer; Jonathan M Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-09       Impact factor: 10.005

2.  NFATc1 balances quiescence and proliferation of skin stem cells.

Authors:  Valerie Horsley; Antonios O Aliprantis; Lisa Polak; Laurie H Glimcher; Elaine Fuchs
Journal:  Cell       Date:  2008-01-25       Impact factor: 41.582

Review 3.  Transcriptional control of the TNF gene.

Authors:  James V Falvo; Alla V Tsytsykova; Anne E Goldfeld
Journal:  Curr Dir Autoimmun       Date:  2010-02-18

4.  Activation of NFAT signaling establishes a tumorigenic microenvironment through cell autonomous and non-cell autonomous mechanisms.

Authors:  P Tripathi; Y Wang; M Coussens; K R Manda; A M Casey; C Lin; E Poyo; J D Pfeifer; N Basappa; C M Bates; L Ma; H Zhang; M Pan; L Ding; F Chen
Journal:  Oncogene       Date:  2013-04-29       Impact factor: 9.867

Review 5.  Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family.

Authors:  Hélène Bour-Jordan; Jonathan H Esensten; Marc Martinez-Llordella; Cristina Penaranda; Melanie Stumpf; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

6.  Activation of NFAT signaling in podocytes causes glomerulosclerosis.

Authors:  Yinqiu Wang; George Jarad; Piyush Tripathi; Minggui Pan; Jeanette Cunningham; Daniel R Martin; Helen Liapis; Jeffrey H Miner; Feng Chen
Journal:  J Am Soc Nephrol       Date:  2010-07-22       Impact factor: 10.121

7.  Prognostic value of members of NFAT family for pan-cancer and a prediction model based on NFAT2 in bladder cancer.

Authors:  Zhou-Tong Dai; Yuan Xiang; Yundan Wang; Le-Yuan Bao; Jun Wang; Jia-Peng Li; Hui-Min Zhang; Zhongxin Lu; Sreenivasan Ponnambalam; Xing-Hua Liao
Journal:  Aging (Albany NY)       Date:  2021-05-07       Impact factor: 5.682

8.  Loss of GTPase of immunity-associated protein 5 (Gimap5) promotes pathogenic CD4+ T-cell development and allergic airway disease.

Authors:  Andrew R Patterson; Paige Bolcas; Kristin Lampe; Rachel Cantrell; Brandy Ruff; Ian Lewkowich; Simon P Hogan; Edith M Janssen; Jack Bleesing; Gurjit K Khurana Hershey; Kasper Hoebe
Journal:  J Allergy Clin Immunol       Date:  2018-10-25       Impact factor: 10.793

Review 9.  Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3).

Authors:  Eléonore Beurel; Suzanne M Michalek; Richard S Jope
Journal:  Trends Immunol       Date:  2009-10-14       Impact factor: 16.687

Review 10.  B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.

Authors:  Mathieu Uzzan; Jean-Frederic Colombel; Andrea Cerutti; Xavier Treton; Saurabh Mehandru
Journal:  Dig Dis Sci       Date:  2016-09-21       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.